Top Markets
Coin of the day
Edesa Biotech, Inc. Edesa Biotech, Inc.

Edesa Biotech, Inc.

EDSA
Rangering i aksjer #25796
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering,... Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
Aksjekurs
$4.80
Sist synkronisert: 2026-08-20
Markedsverdi
$46.24M
Endring (1 dag)
-16.52%
Endring (1 år)
101.68%
Land
CA
Handel Edesa Biotech, Inc. (EDSA)

Kategori

Historikk for aksjesplitt for Edesa Biotech, Inc. (EDSA)
Aksjen Edesa Biotech, Inc. (symbol: EDSA) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 21, 2026.
Én EDSA-aksje kjøpt før Aug 21, 2026 tilsvarer i dag 0 EDSA-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US